Swift Biosciences
Latest round
- Series D
Last raised
- Jun 2017
Total raised
- $26M
Investors
- 7
About Swift Biosciences
Swift Biosciences Inc.Founded in 2010 and headquartered in Ann Arbor, US, Swift Biosciences Inc. develops products focused on genomic analysis. In March 2021, Integrated DNA Technologies, Inc. acquired the company for an undisclosed sum.Swift Biosciences Inc. offers biotechnology solutions aimed at enhancing diagnostic capabilities and advancing life sciences research. Their flagship products incorporate advanced genetic sequencing technologies, facilitating accurate genomic analysis and applications in personalized medicine. These solutions are designed to streamline workflows in clinical laboratories and research institutions, addressing critical needs in disease detection and management. Utilized by healthcare providers, pharmaceutical companies, and academic institutions, their products cover various end-use cases, including cancer research, genetic disorder screening, and infectious disease diagnostics.The revenue model of Swift Biosciences Inc. is primarily based on direct sales and partnerships with key stakeholders in the healthcare and research sectors. Transactions typically occur through B2B arrangements, where clients procure advanced diagnostic products on a subscription basis or through one-time purchases. The pricing structure is tiered, accommodating different client needs and scales, ensuring accessibility for laboratories from small clinical practices to large research facilities.Swift Biosciences Inc. The company is designing new products aimed at improving genetic testing capabilities, with plans for a phased launch in 2022. Furthermore, it intends to expand into emerging markets in Asia and Europe by 2023, leveraging advancements in biotechnology to reach a wider audience.
Who invested in Swift Biosciences
7 investors across 5 rounds
See all investors in Swift Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Swift Biosciences
Who invested in Swift Biosciences?
Swift Biosciences has 7 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Swift Biosciences raised?
Swift Biosciences has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Swift Biosciences last raise money?
Swift Biosciences's most recent round on record is a Series D, in Jun 2017.
What does Swift Biosciences do?
Swift Biosciences is a pharmaceuticals company.
Where is Swift Biosciences headquartered?
Swift Biosciences is headquartered in Ann Arbor, US.
Which VCs invest in companies like Swift Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Swift Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Swift Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.